1. Home
  2. SLDP vs FLGT Comparison

SLDP vs FLGT Comparison

Compare SLDP & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Power Inc.

SLDP

Solid Power Inc.

HOLD

Current Price

$3.82

Market Cap

848.8M

Sector

Energy

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$24.68

Market Cap

867.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDP
FLGT
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
848.8M
867.4M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SLDP
FLGT
Price
$3.82
$24.68
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$7.00
$28.33
AVG Volume (30 Days)
4.7M
175.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$18,730,000.00
Revenue This Year
$4.33
$16.84
Revenue Next Year
$10.19
$9.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$14.57
52 Week High
$8.86
$31.04

Technical Indicators

Market Signals
Indicator
SLDP
FLGT
Relative Strength Index (RSI) 44.60 52.16
Support Level $3.87 $21.97
Resistance Level $4.70 $28.61
Average True Range (ATR) 0.20 0.72
MACD 0.03 0.17
Stochastic Oscillator 75.68 99.18

Price Performance

Historical Comparison
SLDP
FLGT

About SLDP Solid Power Inc.

Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: